Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Olanzapine Clozapine Key study on Schizophrenia and Addiction in the Netherlands (ROCKSAN)
2008-005019-16Phase 3Active
- Sponsor
- AMC Health
- Start
- Nov 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia, schizoaffective disorder, schizophreniform disorder and 1 more comparing Olanzapine arm with Clozapine arm (2 arms). Primary endpoints: Self-reported substance use (CIDI BJL) at month 6 and Recent drug use urine analysis (RDUU) at month 6. Started Nov 2008; status: active.
02
Drugs
olanzapineclozapine
03
Conditions
schizophreniaschizoaffective disorderschizophreniform disordersubstance use disorder (SUD)
Beyond the preview
Go deeper on 2008-005019-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005019-16.